Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-01-17 @ 1:28 PM
Study NCT ID:
NCT03308357
Status:
UNKNOWN
Last Update Posted:
2017-10-13
First Post:
2017-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
Sponsor:
The Alfred
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-03
Completion Date Type:
ESTIMATED
First Submit Date:
2017-10-09
First Submit QC Date:
None
Study First Post Date:
2017-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-12
Last Update Post Date:
2017-10-13
Last Update Post Date Type:
ACTUAL